KDM1A and gastric cancer: In addition, the expression of PD-L1 was decreased by novel LSD1 inhibitors—acridine-based DXJ-1, phenothiazine-based 3s, and quinazoline-based compound Z-1—in gastric cancer cells, and in xenograft tumors [153,154,155].